ES2196328T3 - Derivados de tetrahidrofurano tetraciclicos sustituidos. - Google Patents
Derivados de tetrahidrofurano tetraciclicos sustituidos.Info
- Publication number
- ES2196328T3 ES2196328T3 ES97920662T ES97920662T ES2196328T3 ES 2196328 T3 ES2196328 T3 ES 2196328T3 ES 97920662 T ES97920662 T ES 97920662T ES 97920662 T ES97920662 T ES 97920662T ES 2196328 T3 ES2196328 T3 ES 2196328T3
- Authority
- ES
- Spain
- Prior art keywords
- rent
- independently
- replaced
- halometilo
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 title 1
- -1 CYANO, HYDROXYL Chemical class 0.000 abstract 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), A SUS FORMAS DE N - OXIDOS, A SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES Y A LAS FORMAS ESTEREOISOMERICAS DE LOS MISMOS, DONDE N ESTA COMPRENDIDO ENTRE 0 Y 6; P Y Q ESTAN COMPRENDIDOS ENTRE 0 Y 4; R ESTA COMPRENDIDO ENTRE 0 Y 5; R 1 Y R 2 , CADA UNO INDEPENDIENTEMENTE, SON HIDROGENO, ALQUILO C 1-6 , ALQUILCARBONILO C 1-6 O HALOMETILCARBONILO, OPCIONAL MENTE SUSTITUIDOS; O R 1 Y R 2 , CONJUNTAMENTE CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS, PUEDEN FORMAR UN CICLOMORFOLINILO O UN HETEROCICLO OPCIONALMENTE SUSTITUIDO; Y CADA UNO DE R 3 Y R 4 ES INDEPENDIENTEMENTE HALO, CIANO, HIDROXILO, HALOMETILO, HALOMETOXI, CARBONILO, NITRO, AMINO, MONO - O DI(ALQUIL C 1-6 )AMINO, ALQUILCARBONILAMINO C 1 -6 , AMINOSULFONILO, MONO - O DI(ALQUIL C 16 )AMINOSULFONILO, ALQUILO C 1-6 , ALQUILOXI C 1-6 , ALQUILCARBONILO C 1-6 , ALQUILOXICARBONILO C 1-6 ; SIENDO CADA R 5 INDEPENDIENTEMENTE ALQUILO C 1-6 , CIANO O HALOMETILO; X ES CR 6 R 7 , NR 8 , O,S, S(= O) 2 ; EL ARILO PUEDE SER FENILO SUSTITUIDO OPCIONALMENTE; A CONDICION DE QUE EL COMPONENTE SEA DISTINTO DE ACIDO ( (MAS MENOS) )3,3A,8,12B -TETRAHIDRO - N - METIL - 2H - DIBENZO[3,4;6,7] CICLOHEPTA[1,2 -B] - FURAN - 2 - METANAMINA OXALICO. LOS COMPUESTOS DE FORMULA (I) SE PUEDEN UTILIZAR COMO AGENTES TERAPEUTICOS PARA EL TRATAMIENTO O PREVENCION DE ALTERACIONES DEL SNC, ALTERACIONES CARDIOVASCULARES O GASTROINTESTINALES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200990 | 1996-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196328T3 true ES2196328T3 (es) | 2003-12-16 |
Family
ID=8223868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97920662T Expired - Lifetime ES2196328T3 (es) | 1996-04-12 | 1997-04-09 | Derivados de tetrahidrofurano tetraciclicos sustituidos. |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US6057441A (es) |
| EP (1) | EP0892793B1 (es) |
| JP (1) | JP3199751B2 (es) |
| KR (1) | KR100389298B1 (es) |
| CN (1) | CN1116291C (es) |
| AT (1) | ATE236893T1 (es) |
| BG (1) | BG63083B1 (es) |
| BR (1) | BR9706639A (es) |
| CA (1) | CA2232141C (es) |
| CY (1) | CY2382B1 (es) |
| CZ (1) | CZ288865B6 (es) |
| DE (1) | DE69720709T2 (es) |
| DK (1) | DK0892793T3 (es) |
| EA (1) | EA001002B1 (es) |
| EE (1) | EE03612B1 (es) |
| ES (1) | ES2196328T3 (es) |
| HK (1) | HK1015771A1 (es) |
| HU (1) | HUP9901613A3 (es) |
| IL (1) | IL123655A (es) |
| MY (1) | MY119321A (es) |
| NO (1) | NO317156B1 (es) |
| NZ (1) | NZ329953A (es) |
| PL (1) | PL190960B1 (es) |
| PT (1) | PT892793E (es) |
| SI (1) | SI0892793T1 (es) |
| SK (1) | SK283400B6 (es) |
| TR (1) | TR199801164T2 (es) |
| TW (1) | TW504506B (es) |
| WO (1) | WO1997038991A1 (es) |
| ZA (1) | ZA973114B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ329953A (en) * | 1996-04-12 | 1999-06-29 | Janssen Pharmaceutica Nv | Substituted tetracyclic n-oxide tetrahydrofuran derivatives, salts and stereoisomeric forms thereof for the treatment of cns cardiovascular or gastrointestinal disorders |
| UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
| US20050148018A1 (en) | 1999-10-07 | 2005-07-07 | David Weiner | Methods of identifying inverse agonists of the serotonin 2A receptor |
| HRP20000310A2 (en) * | 2000-05-17 | 2002-02-28 | Pliva Farmaceutska Ind Dioniko | New dibenzoazulene compounds as tumor necrosis factor inhibitors |
| WO2002056873A2 (en) * | 2000-12-22 | 2002-07-25 | Bayer Pharmaceuticals Corporation | 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues |
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| US7205335B2 (en) * | 2001-12-07 | 2007-04-17 | Mao Hua | Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| CA2468038C (en) * | 2001-12-07 | 2011-04-26 | Janssen Pharmaceutica Nv | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| HRP20020305A8 (en) | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
| HRP20030885A2 (en) * | 2003-11-03 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS |
| HRP20030956A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU |
| HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030953A2 (en) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030957A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030958A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| TW200612899A (en) * | 2004-06-14 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel tetracyclic tetrahydrofuran derivatives |
| WO2006000555A2 (en) | 2004-06-23 | 2006-01-05 | Janssen Pharmaceutica N.V. | Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| WO2006061392A2 (en) | 2004-12-07 | 2006-06-15 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| AU2011202995B2 (en) * | 2004-12-07 | 2012-02-02 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| ES2391780T3 (es) * | 2005-01-27 | 2012-11-29 | Janssen Pharmaceutica Nv | Derivados de tetrahidrofurano tetracíclicos como inhibidores de 5HT2 en el tratamiento de trastornos de SNC |
| AU2006248956C1 (en) * | 2005-05-19 | 2012-02-02 | Janssen Pharmaceutica N.V. | Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| CA2604165A1 (en) * | 2005-05-26 | 2006-11-30 | Janssen Pharmaceutica N.V. | Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| ES2342110T3 (es) * | 2005-06-17 | 2010-07-01 | Janssen Pharmaceutica Nv | Nuevos derivados tetraciclicos de tetrahidrofurano que contienen una cadena lateral de amina ciclica. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| DE2742794A1 (de) * | 1976-11-15 | 1978-05-18 | Dec Int | Vorrichtung zur befoerderung von gemahlenem kaese |
| DE68924751T2 (de) * | 1988-09-26 | 1996-04-11 | Smithkline Beecham Farma | Azacyclische Verbindungen, verwendbar als Arzneimittel. |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| FR2681320B1 (fr) * | 1991-09-12 | 1994-01-14 | Synthelabo | Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique. |
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| US5981539A (en) * | 1995-09-15 | 1999-11-09 | Neurosearch A/S | Piperidine compounds as calcium channel blockers |
| NZ329953A (en) * | 1996-04-12 | 1999-06-29 | Janssen Pharmaceutica Nv | Substituted tetracyclic n-oxide tetrahydrofuran derivatives, salts and stereoisomeric forms thereof for the treatment of cns cardiovascular or gastrointestinal disorders |
-
1997
- 1997-04-09 NZ NZ329953A patent/NZ329953A/xx not_active IP Right Cessation
- 1997-04-09 IL IL12365597A patent/IL123655A/xx not_active IP Right Cessation
- 1997-04-09 PT PT97920662T patent/PT892793E/pt unknown
- 1997-04-09 EA EA199800348A patent/EA001002B1/ru not_active IP Right Cessation
- 1997-04-09 US US09/155,840 patent/US6057441A/en not_active Expired - Lifetime
- 1997-04-09 DE DE69720709T patent/DE69720709T2/de not_active Expired - Lifetime
- 1997-04-09 EP EP97920662A patent/EP0892793B1/en not_active Expired - Lifetime
- 1997-04-09 WO PCT/EP1997/001829 patent/WO1997038991A1/en active IP Right Grant
- 1997-04-09 CZ CZ19983243A patent/CZ288865B6/cs not_active IP Right Cessation
- 1997-04-09 TR TR1998/01164T patent/TR199801164T2/xx unknown
- 1997-04-09 BR BR9706639A patent/BR9706639A/pt not_active IP Right Cessation
- 1997-04-09 HU HU9901613A patent/HUP9901613A3/hu unknown
- 1997-04-09 CA CA002232141A patent/CA2232141C/en not_active Expired - Fee Related
- 1997-04-09 AT AT97920662T patent/ATE236893T1/de active
- 1997-04-09 ES ES97920662T patent/ES2196328T3/es not_active Expired - Lifetime
- 1997-04-09 SK SK1418-98A patent/SK283400B6/sk unknown
- 1997-04-09 KR KR10-1998-0703536A patent/KR100389298B1/ko not_active IP Right Cessation
- 1997-04-09 JP JP53673397A patent/JP3199751B2/ja not_active Expired - Fee Related
- 1997-04-09 PL PL328575A patent/PL190960B1/pl not_active IP Right Cessation
- 1997-04-09 DK DK97920662T patent/DK0892793T3/da active
- 1997-04-09 SI SI9730551T patent/SI0892793T1/xx unknown
- 1997-04-09 CN CN97191422A patent/CN1116291C/zh not_active Expired - Fee Related
- 1997-04-09 EE EE9800326A patent/EE03612B1/xx not_active IP Right Cessation
- 1997-04-10 TW TW086104563A patent/TW504506B/zh not_active IP Right Cessation
- 1997-04-11 ZA ZA973114A patent/ZA973114B/xx unknown
- 1997-04-11 MY MYPI97001598A patent/MY119321A/en unknown
-
1998
- 1998-03-11 NO NO19981076A patent/NO317156B1/no not_active IP Right Cessation
- 1998-10-07 BG BG102820A patent/BG63083B1/bg unknown
-
1999
- 1999-02-22 HK HK99100700A patent/HK1015771A1/xx not_active IP Right Cessation
-
2000
- 2000-03-22 US US09/533,625 patent/US6194405B1/en not_active Expired - Lifetime
- 2000-12-21 US US09/745,517 patent/US6288058B1/en not_active Expired - Fee Related
-
2003
- 2003-11-04 CY CY0300077A patent/CY2382B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2196328T3 (es) | Derivados de tetrahidrofurano tetraciclicos sustituidos. | |
| PA8593101A1 (es) | Composiciones para el tratamiento de crecimiento celular anormal | |
| CO5590904A2 (es) | Esteriodes 3-nitrogen-6,7-dioxigeno y usos relacionados con este | |
| UY27322A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
| AR018705A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos. | |
| ES2159839T3 (es) | Derivados del propano, su preparacion y su uso. | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| PA8578601A1 (es) | Derivados de 2,2- difenil-benzodioxol | |
| UY26323A1 (es) | Los inhibidores triciclicos de poli (adp-ribosa) polimerasas | |
| PA8480101A1 (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos | |
| SV2002000504A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal ref.pc10760/20205/bb | |
| AR054438A1 (es) | Inhibidores de adn -pk | |
| UY27503A1 (es) | Nuevos derivados de piperazina | |
| ATE277072T1 (de) | Sapogenin derivate zur behandlung von kognitiven störungen | |
| CO4790154A1 (es) | Compuestos heterociclicos como inhibidores de enzimas rota- masas | |
| ES2189941T3 (es) | Derivados de nucleosidos aciclicos. | |
| ES2188984T3 (es) | Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas. | |
| UY27232A1 (es) | Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos | |
| PA8574401A1 (es) | Derivados de n-acilamino bencil eter como inhibidores de mao-b | |
| ES2171911T3 (es) | Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos. | |
| ES2145379T3 (es) | Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral. | |
| CO4290299A1 (es) | Derivados de 1,5-benzodiazepina | |
| ES2055472T3 (es) | Estabilizacion de poliisocianatos organicos. | |
| CL2004000519A1 (es) | Composicion herbicida que comprende 3-(3-sulfamoil carboxamida fenil) uracilos y por lo menos otro herbicida seleccionado entre 6 posibilidades y opcionalmente un protector; agente herbicida que comprende la composicion; metodo para controlar la vege | |
| ES2155898T3 (es) | Derivados de azepina tetraciclica sustituidos, que presentan una afinidad por los receptores 5-ht2. |